<DOC>
	<DOCNO>NCT01948648</DOCNO>
	<brief_summary>If treatment colesevelam , fish oil conjunction ezetimibe , lead reduction plasma plant sterol level sitosterolemia patient . We hypothesize treatment fish oil , colesevelam ezetimibe maximize decrease plasma concentration sitosterol plant sterol sitosterolemia patient .</brief_summary>
	<brief_title>Effects Fish Oil Colesevelam</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>1 . Confirmed diagnosis homozygous sitosterolemia establish genotyping and/or clinical parameter 2 . Receiving ezetimibe treatment 3 . Over 12 year age ( maximum ) 4 . Concomitant illness condition 1 . Pregnancy 2 . Intellectual disability 3 . Bowel biliary obstruction 4 . Known hypersensitivity colesevelam ingredient colesevelam</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>plant sterol</keyword>
	<keyword>cholesterol</keyword>
	<keyword>colesevelam</keyword>
	<keyword>phytosterolemia</keyword>
	<keyword>fish oil</keyword>
</DOC>